在紧急护理研究中对比较有效性试验的知情同意的例外和知情同意的豁免
Jonathan D Casey1, Matthew W Semler2, Jeremy Brown3
1Assistant professor of medicine in the Division of Allergy, Pulmonary, and Critical Care Medicine at the Vanderbilt Center for Learning Healthcare and the Vanderbilt Institute for Clinical and Translational Research at Vanderbilt University Medical Center.
Ethics & human research
|December 31, 2025
概括
临床医生需要更多的证据来做出治疗决策,特别是在紧急护理中. 对伦理和监管监督的审查对于比较有效性研究至关重要,以改善患者的治疗结果.
科学领域:
- 临床医学 临床医学
- 医疗保健服务研究 医疗服务研究
- 生物伦理学生物伦理学
背景情况:
- 临床医生往往缺乏基于证据的治疗决策指导,特别是在紧急护理环境中.
- 紧急的患者状况和紧急护理中的治疗需求经常会阻止研究的潜在知情同意.
- 美国现有的监管框架对于低至最小风险的比较有效性试验是不够的.
研究的目的:
- 通过促进大规模的比较疗效临床试验,解决临床医学中的证据缺口.
- 确定和讨论在紧急护理中进行比较有效性研究的挑战和潜在解决方案.
- 探索知情同意和监管途径对此类试验的作用.
主要方法:
- 总结来自国家卫生研究院 (NIH) 研讨会的讨论.
- 专注于在紧急情况下进行比较有效性试验的伦理考虑和监管途径.
- 分析在临床护理中进行社会价值研究的障碍.
主要成果:
- 目前的伦理和监管实践阻碍了生成重要的比较有效性数据.
- 研讨会强调需要对监管进行修订,以支持比较常用的治疗方法的研究.
- 美国对于低至最小风险试验缺乏明确的监管框架.
结论:
- 修订伦理和监管监督是必要的,以生成比较有效性数据.
- 需要改进的指导来支持紧急护理中的比较有效性试验.
- 解决这些问题最终将改善患者的治疗结果和临床护理.
相关概念视频
01:13Bioequivalence studies: Biowaivers
203
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
203
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
376
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
376
01:56Ethics in Research
25.3K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
25.3K
01:11Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
01:12Hazard Ratio
548
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
548
01:22Standards of Care I
1.0K
Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
1.0K